DNL-919 (TAK-920) is a human IgG1 monoclonal antibody (mAb) targeting TREM-2. DNL-919 can be used in Alzheimers disease research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Molecular Weight:
(145.24 kDa)
Purity:
96.17
Target:
TREM receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
